Today, the same justices who undid constitutional protection for abortion will hear arguments in the next frontier of abortion restriction: tightening access across the country for a medication that's used in nearly two-thirds of all abortions nationally.
Novo Nordisk said Monday it had agreed to buy Cardior Pharmaceuticals for up to 1.03 billion euros ($1.1 billion) to strengthen its cardiovascular pipeline.
The biotech company is testing an injectable treatment that helps people lose weight differently. Amgen's treatment, called MariTide, also appears to help patients keep weight off after they stop taking it.